Rautou PE, Cazals-Hatem D, Moreau R, Francoz C, Feldmann G, Lebrec D, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.
Epub 5.ĭas K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr. 10.1371/journal.pone.0173499Ĭortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. Le MH, Devaki P, Ha NB, Jun DW, Te HS, Cheung RC, et al. The left part of the figure shows the corresponding T2 images without (1a, 3a) and with (1b, 3b) fat saturation, revealing a relative signal loss of 36% (1b) or 23% (1b).īyrne CD, Targher G.
The T1 weighted image 4 (with magnification on the left) shows the corresponding normal weight control (29 years, female, Crohn’s disease), who was also examined at a field strength of 1.5 T, but who does not show any sign of fatty liver with a normal liver signal on the T1-weighted image. The patient was revealed to have a fatty liver with hyperintensity on the T1-weighted sequence. The T1-weighted image 3 (with magnification on the left) shows a patient case example of a 27-year old woman with Crohn’s Disease, who was examined at 1.5 T. The T1 weighted image 2 (with magnification on the left) shows the corresponding normal weight control (22 years, female, no diagnosis), who was also examined at a field strength of 3T, but who does not show any sign of fatty liver and no hyperintensity on the T1-weighted image. The T1-weighted image 1 (with magnification on the left) shows a patient case example of a 21-year old woman with indistinct stomach pains, but without diagnosis of physical disorders, who was examined at 3T.
This does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role the study design collection, analysis, and interpretation of data writing of the paper and/or decision to submit for publication. The remaining authors have no conflicts of interest and did not receive any funds. LCA is part of the BIH Charité - Junior Clinician Scientist Program funded by the Charité - Universitaetsmedizin Berlin and the Berlin Institute of Health. MRM has received grants from the Deutsche Forschungsgesellschaft (DFG) (1, SFB 1340). Galmed Research and Development Ltd., 102. AIO: Arbeitsgemeinschaft Internistische Onkologie, 69. Sehumaeher GmbH (Sponsoring eines Workshops), 64. ICON (Clinical Research Organisation), 54. PPD (Clinical Research Organisation), 45. Parexel Clinical Research Organisation Service, 26. Focused Ultrasound Surgery Foundation, 14. Also, underweight patients showed slightly increased liver enzymes and liver diameters, hinting at initial metabolic disturbances.īH has received research grants for the Department of Radiology, Charité – Universitätsmedizin Berlin from the following companies: 1. The prevalence of liver steatosis was higher among underweight IBD and non-IBD patients compared to normal weight controls. In this cross-sectional age, gender and disease-matched case-control study, underweight patients (BMI0.05). So far, the prevalence of NAFLD in underweight individuals with and without inflammatory bowel disease (IBD) is insufficiently enlightened. Non-alcoholic fatty liver disease (NAFLD) was shown to also occur in lean and underweight patients.
0 kommentar(er)
